Bradley Anawalt, MD
Disclosures:
BRADLEY D

BRADLEY D. ANAWALT, MD, FACP

Curriculum Vitae

November 2016

                                                       

Personal Data

             

              Place of Birth:                                            San Francisco, California

             

              Present address:                                          7217 36th Ave SW

                                                                      Seattle, WA  98126

 

 

Education

 

              Undergraduate:                                            Santa Clara University; BS, 1984

                                                                     

              Medical                                                        University of California, Davis

                                                                      School of Medicine; MD, 1989

                                                                     

Postgraduate training

 

              Internship and Residency:                University of Washington Affiliated Hospitals, Seattle,                                                                                                   Washington, 1989-1992

                                                                      Internal Medicine

 

              Chief residency:                                          VA Puget Sound Health Care System, 1993

                                                                      Internal Medicine

 

Fellowship:              University of Washington Affiliated Hospitals, Seattle, Washington, 1993-1995

                                                                      Endocrinology

 

Faculty positions             

Vice Chair of Medicine, Department of Medicine, University of Washington, 2008-present

Full Professor, University of Washington, 2007-present

Associate Professor, University of Washington, 2001-2007

                                                                      Assistant Professor, University of Washington, 1997-2001

                                                                      Acting Instructor, University of Washington, 1995-1997

 

Hospital positions

University of Washington Medical Center

Chief of Medicine, 2008-present

Chief of Staff, 2015-16

 

VA Puget Sound Health Care System

                                                                      Associate Chief of Medicine, 2001-2008

                                                                      Associate Care Line Manager of Primary & Specialty Care

2001-2008

 

                                                                      Director, Resident Ambulatory Care Training, VAPSHCS

                                                                      1995-2001

 

Associate Residency Program Director, University of Washington, 2003-2007

 

Staff physician, General Internal Medicine and Endocrinology

                                                                      1995-2008

 

Honors

                            Undergraduate:                            Honors Program

                                                                      Cum Laude

                                                                      Dean's List

                                                                      Sigma Xi, a national scientific research society

                                                                      Krassowski Award for exemplary anthropological thesis

                                                                      Western Anthropology Undergraduate Conference, 1984

 

                            Medical school:                            Alpha Omega Alpha (Junior), 1988

                                                                      Merck Award for outstanding scholarship, 1989

 

                            Professional:                            1997 Endocrine Society Travel Award

                                                                      1999 Endocrine Society Travel Award

1999 University of Washington Paul Beeson Award (for excellence in teaching)

                                                                      2005 America’s Best Doctors

2005 The Endocrine Society and Pfizer, Inc. International Award for Excellence in Published Clinical Research in The Journal of Clinical Endocrinology & Metabolism in 2004

2004, 2005, 2007 Outstanding Federal Employee honoree

2007 University of Washington Endocrinology Fellows’ Teaching Award

2008 America’s Best Doctors

2008 Washington State’s Best Doctors (Washington State Magazine)

2012 Outstanding Reviewer Award, Journal of Clinical Endocrinology and Metabolism

2013 Best Clinical Management Forum, 2012 Endocrine Society Annual Meeting, Houston, TX

2014 University of Washington Department of Medicine Marvin Turck Award for Excellence in Teaching

2014 Seattle’s Best Doctors, (Seattle Met Magazine)

2014 Top Honors (Gold) for best microsite from Web Health Awards—awarded for Menopause Map, a web-based patient education site visited by more than 60,000 women in 2014.  Co-author and editor.

 

Board Certification:

 

                            American Board of Internal Medicine-1992, 2002, 2015

                            American Board of Endocrinology-1995, 2005

 

Licensure:              Washington State, 1991

 

Professional Organizations:

Fellow, American College of Physicians, (member since 1993)

Member, American Federation of Medical Research, 1995-2012

Member, Andrology Society, 1999-present

Member, Association of Program Directors in Internal Medicine, 2003-2008

Member, Western Association of Physicians, 2007-present

Member, Western Society of Clinical Investigators, 2013-present

Member, The Endocrine Society, 1993-present

 

 

 

 

Teaching Responsibilities

 

Medical student teaching activities

Endocrinology Core Course (HuBio 544)

              -Co-director 2010-present

-Course Director, 2003-2010

-Lecturer and small group leader, 1995-present

 

 

Endocrinology elective course instructor for second year medical students (Med 553), 1995-2013?

-Gave one of the principal lectures (“Male hypogonadism”)

 

Human reproduction core course for second year medical students (Hubio 565) 1999-2001

-Gave one of the principal lectures (“Female sexuality”)

 

Cellular physiology (Hubio 512), 2006-2008

-Gave one of the principal lectures (“Pheochromocytoma”)

 

Evidence-based medicine (Hubio 590), 2002-2005

-small group instructor

 

MS 665 course (introduction to history taking and physical exam for second year medical students)

              -preceptor and as examiner 1998-2000, 2003

 

Capstone instructor, Inpatient glucose management, 2009-present

 

House staff teaching activities

 

VA resident report 3-4 months per year, 1995-2007

VA intern’s report monthly, 1995-2005

Senior resident course small group leader and speaker (“Role of the senior resident:  team manager, teacher, leader”), 1992-2004

Endocrinology post-clinic conference organizer, 1995-2001

VA GIMC pre-clinic conference organizer, 1995-2001

Served as mentor to clinician-teacher fellows 1995-2001:  Trainees include Rattan Junega, Therese Dawson, Nicole Grant, Carmen Berger, Sarah Clever, Kirsten Anawalt, Jeanne Vesey, Chris Cable, Alexi Weil, Rachelle Bernacki, Emily Darby

 

 

Fellow teaching activities

Board review lectures—gonadal disorders + board review cases, 1996- 2008?

Fellows’ Survival Course:  7/10-present

 

Attending teaching activities

VA dinner series organizer, 1999-2002

 

 

Editorial Responsibilities

 

Editorial Board, Journal of Clinical Endocrinology and Metabolism, 2006-2010 and 2010-2014 (25 articles/yesr)

Editorial Board, Journal of Clinical Endocrinology, 2011-2012 (20 articles/year)

Editor, North America, Journal of Clinical Endocrinology, 2012-2015 (250 articles/year)

Associate Editor, Endocrine Reviews, 2015-2018 (250 articles/year)

 

 

                           

Special Regional and National Responsibilities

VA

National Viagra Task Force Committee, 1998-99

National Primary Care Provider Reports Task Force, 2006-2008

VISN Equipment Committee, 2004-2007

VISN Primary Care Committee, 2004-2007

VISN Teleretinal Imaging Committee, 2005-2005

 

 

American Federation of Medical Research

President of Western Society, 2004-05

President Ex-Officio of Western Society, 2005-2006

University of Washington representative, 2000-2006                           

Lead Reviewer and session chair, Western Meeting of American Federation Medical Research meeting, 2000-2008, 2010, 2014

 

Endocrine Days Steering Committee member 2000-present

Endocrine Days Vice President, 2007-present

 

Endocrine Society

Session chair, National meeting, Denver 6/01

Lead reviewer and session chair, National meeting, San Francisco 6/02

CME Program Director, CME Ancillary Session, National meeting, New Orleans, 6/04

Session chair, National meeting, New Orleans 6/04

Special Program Committee, 2004-2007

Reviewer, National meeting, Boston, 6/06

Reviewer, International meeting, Toronto, 6/07

Annual Meeting Steering Committee, 2007-2010

CME Program Director, CME Ancillary Session, National meeting, San Diego, 6/09

ENDO Task Force, 2009-2010

Annual Meeting, Clinical Chair, 2010-2011

                            Hormone Health Network

Chair, 2010-2014

Men’s Health Task Force Committee, 2005-present

Testosterone Tour author, 2013

Menopause map co-editor ,2014

 

ES Branding Task Force, 2013

Male Hypogonadism Practice Improvement Module Committee (and author), 2013-14

Male Hypogonadism Maintenance of Certification Module author, 2013-14

Council Member, elected to term of office 2014-17

 

             

Journal reviewer

2004- present:  Journal of Clinical Endocrinology & Metabolism, Asian Journal of Andrology

2001 Ad Hoc Editorial Board of Fertility and Sterility, member

1999-present Ad Hoc Reviewer: Lancet, Journal of Andrology, Journal of Urology, New England Journal of Medicine

 

American Board Internal Medicine, Continuing Program Development Question-Writer, 2003-04

Self-assessment Program Question-Writer for board re-certification, 2004-present;  Lead Question Writer, 2014-present

 

United States Anti-Doping Agency, Therapeutics Use Exemption committee member, 2004-present

 

Elsevier USMLE Board Review Question Reviewer, 2005

 

Andrology Society Proficiency Examination Committee, Member 2006-2011

 

             

Special Local Responsibilities

University of Washington Department of Medicine:

Resident Clinical Competency Review, 1995-2005

Primary Care Curriculum Development, 1997-2001

General medicine teaching committee (co-chair), 1998-2001

Roosevelt Clinic Faculty Search committee 1999

VA GIMC Faculty Search Committee Chairman 2002

VA Nephrology Faculty Search Committee 2005

Residency Selection Committee, 2001-2009

Education Committee, 2001-2008

UW Basic Science Teaching Committee, 2004-06

UWSOM 2nd year Curriculum Committee, 2003-present

Education Program Task Force, 2006-present

Department of Medicine News Advisory Board, 2006-present

Faculty Senate, 2005-2008

Department of Medicine Appointments and Promotions Committee, 2006-2009

Department of Medicine Appointments and Promotions Committee Chair, 2009-present

UWMC

                            UWP Clinical Practice Committee, Chair 2009-2014

                            UWMC Chief of Staff, 2015-2016             

                                                                     

VA Puget Sound:

GIMC faculty search committee, 1997-1998

Diabetes care task force (chair), 1995-1997

PRIME committee, 1995-2000

VA PSHCS Sildenafil Review Committee, 1998-99

Patient Education Committee, 1998-present

Women’s Advisory Committee, 2001-present

Clinical Research Unit Committee, 2002-present

Chair of GIMC faculty search committee, 2001-2002

VA Boise, Chief of Medicine search committee, 2001-2002

Primary Care Council (chair), 2002- 2005

Primary Care Steering Committee, 2002- present

Equipment Committee, 2002-present

Restraint Management Committee, 2002- present

Emergency Preparedness Committee, 2002-present

Clinical Research Unit Committee, 2002-present

Biomedical Scientific Review Committee, 2002-2005

VISN 20 Equipment Committee, 2002-present

VA Nephrology Search Committee, 2005-2007

VA Boise, Associate Residency Program Director search committee, 2006-07

 

Research Activities

 

9/2015-9/2020                            NICHD Contract HHSN2752013000251

Clinical Evaluation of Male Contraceptives Core Function Activities (Contraceptive Clinical Trials Network)

PI:  William J. Bremner, MD, PhD

Bradley D. Anawalt, Co-Investigator

$53,624/year

9/2015-9/2019                            NIH-NIHCD HHSN2752013000251

                                          Male Clinical Evaluation of Nesterone Gel and Testosterone Gel for Male Contraception

Principal Investigator:  Stephanie T Page, MD, PhD

Bradley D. Anawalt, Co-Investigator

$473,541.60/year

 

9/2014-5/2016              NIH-NIHCD HHSN275201300003

Single Dose, Dose-Ranging and 28 Days Repeat-Dose Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Dimethandrolone Undecanoate (DMAU) in Healthy Men

Principal Investigator:  Stephanie T. Page

Co-Investigator:  Brad Anawalt

Total Direct Costs:  $740,000

 

3/2007-3/2012                    NIH-NICHD U554 HD042454-06

PI: William J. Bremner, MD, PhD

“Male Contraception Research Center Grant”             

              Project I, PI: John K. Amory, MD

              Bradley D. Anawalt, Co-Investigator

              “Oral Testosterone for Male Hormonal Contraception”

              $1,464,204/year

 

Project V: PI: William J. Bremner, MD, PhD

Bradley D. Anawalt, Co-investigator,

“Prostate and Cardiovascular Effects of Male Hormonal Contraceptive Regimens”                              

$1,864,880/year

7/2006-7/2011                        NIH-NICHD-RFA-HD-04-030 PI: Robert E. Braun, PhD

              Specialized Cooperative Centers Program in Reproduction Research”             

Project V: PI: William J. Bremner, MD, PhD

Bradley D Anawalt, Co-Investigator

“Gonadotropin Regulation of Steroidogenesis, Spermatogenesis and Gene Expression in Man”                           

$996,795/year

 

11/2004-09                            Testosterone Replacement and Dutasteride Effectiveness (TRADE)

PI: Alvin M. Matsumoto MD

Bradley D Anawalt, Co-investigator

Investigator-initiated study to determine the effect of testosterone or testosterone plus the 5-reductase inhibitor dutasteride on prostate size, hormones, and gene expression in older, hypogonadal men with benign prostatic hyperplasia.

Funding source:  GlaxoSmithKline and Solvay Pharmaceuticals

$479,000/year

 

1/2007-1/2009                            Monthly ibandronate for men with osteoporosis

PI: Bradley D Anawalt

Funding source: GlaxoSmithKline ($75,000/year)

 

7/2002-6/2007                   Male Contraception Research Center Grant supported by NICHD U54HD42454

PI;  WJ Bremner, MD, PhD

Bradley D Anawalt, Co-investigator

Funding source:  NIH ($1,048,000/year)

7/01-6/03

Androgen replacement therapy in men:

A multicenter clinical trial to validate patient-reported outcome measures of testosterone deficiency

Bradley D Anawalt, Principal investigator

Funding source:  Organon – Amount of Funding?

 

Bibliography

 

Articles in Refereed Journals

  1. Walter RM, Anawalt BD, Grecu EO, Okimura MD.  Thyrotropin-releasing hormone may be a nonspecific stimulator of growth hormone in humans.  Pharmacol. (Life Sci. Adv.) 9:717-722,1990.
  2. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield J, and Keen CL.  Copper, zinc, manganese and magnesium status and complications of diabetes mellitus.  Diabetes Care, 14:1050-56,1991.
  3. Anawalt BD and Matsumoto AM.  Treatment of the hypogonadal male.  Current Opinion in Endocrinology and Diabetes.  2:476-482, 1995.             
  4. Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, and Matsumoto AM.  Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone:  a promising male contraceptive approach.  J Clin Endocrinol Metab  81:757-762, 1996.             
  5. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly A, and Bremner WJ.  Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction.  J Clin Endocrinol Metab 81:3341-3345, 1996.
  6. Anawalt BD, Bebb RA, and Matsumoto AM.  Medical therapy of erectile dysfunction.  Current Opinion in Endocrinology and Diabetes 3 (6):472-477, 1996.
  7. Bebb RA and Anawalt BD.  Diabetic Neuropathy.  British Columbia Medical Journal 3(1):37-41, 1997.
  8. Anawalt BD and Bebb RA.  Update on medical therapy of erectile dyfunction.  Current Opinion in Endocrinology and Diabetes 4 (6):387-391, 1997.             
  9. Zhengwei Y, Wreford NG, Bremner WJ, Matsumoto AM, Anawalt BD and McLachlan RI.  Immature spermatids are not prevalent in semen from men who are receiving androgen-based contraceptive regimens.  Fertility & Sterility.  69(1):89-95, 1998.  
  10. Bradley KA, Badrinath S, Korell K, Boyd-Wickizer, J and Anawalt BD.  Medical risks for women who drink alcohol.  J Gen Int Med  13:627-39, 1998.
  11. Anawalt BD.  New therapies for erectile dysfunction.  Current Practice of Medicine.  1:31-34, 1998.
  12. Swerdloff RS, Bagatell CJ, Wang C, Anawalt BD, Berman N, Steiner B, and Bremner WJ.  Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.  J Clin Endocrinol Metab  83:3527-3533, 1998.
  13. Anawalt BD, Bebb RA, Bremner WJ and Matsumoto AM.  A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic side effects than higher dosage combinations.  J Androl  20:407-414, 1999.
  14. Anawalt BD, Herbst KL, Matsumoto AM, Coelingh-Bennick H, Mulders T and Bremner WJ.  Desogestrel plus testosterone effectively suppresses spermatogenesis but causes a dosage-dependent weight gain and HDL cholesterol suppression.  Fert & Steril  74:707-714, 2000.
  15. Amory JK, Anawalt BD, Paulsen CA, and Bremner WJ.  Klinefelter’s syndrome.  Lancet, 356:333-335,2000.
  16. Anawalt BD and Merriam GR.  Neuroendocrine aging in men:  andropause and somatopause.  Endocrinology and Metabolism Clinics of North America 30:647-671, 2001.
  17. Anawalt BD.  Update on male contraception. Expert Opin Pharmacother 2:1389-1398, 2001.
  18. Anawalt BD and Amory JK.  Advances in male contraception.  Annals of Medicine, 33:587-595, 2001.
  19. Amory JK, Anawalt BD, Bremner WJ, Matsumoto AM.  Daily testosterone and gonadotropin levels are similar in azoospermic and non-azoospermic normal men administered weekly testosterone:  implications for male contraceptive development.  J Androl, 22:1053-1060, 2001.
  20. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, and Siscovick DS.  Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.  Am J Med.  111:261-269, 2001.
  21. Amory JK, Anawalt BD, Blaskovich PD, Gilchriest J, Nuwayser ES, Matsumoto AM.  Testosterone release from a subcutaneous, biodegradable microcapsule formulation in hypogonadal men.  J Androl, 23:84-91, 2002.
  22. Dick SE, DeWitt DE and Anawalt BD.  Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia. American Journal of Managed Care, 8:95-104, 2002.
  23. Cherrier MM, Anawalt BD, Herbst KL, Amory JK, Craft S, Matsumoto AM, Bremner WJ.  Cognitive effects of short term, exogenously manipulated testosterone levels in healthy young men.  J Clin Endocrinol Metab, 87:3090-3096,2002.
  24. Herbst KL, Anawalt BD, Amory JK, Bremner WJ.  Acyline:  The first study in humans of a potent, new gonadotropin-releasing hormone antagonist.  J Clin Endocrinol Metab, 87:3215-3220,2002.
  25. Achtmeyer CE, Payne TH, Anawalt BD.  Computer order entry system decreased use of  sliding scale insulin regimens .  Methods Inf Med, 41(4)277-81,2002.
  26. Grant NN and Anawalt BD.  Male hormonal contraception:  An update on research progress.  Treat Endocrinol, 4;217-227, 2002.
  27. Amory JK, Chansky HA, Chansky KL, Camuso MR, Hoey CT, Anawalt BD, Matsumoto AM, Bremner WJ.  Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery.J Am Geriatr Soc. Oct;50(10):1698-701, 2002.
  28. Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ.  The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    J Clin Endocrinol Metab. 88(3):1167-73, 2003.
  29. Grant NN and Anawalt BD.  Male hypogonadism in the primary care clinic.  Prim Care, 30:743-764, 2003.
  30. Cornia PB and Anawalt BD.  Rational use of perioperative corticosteroid supplementation in patients at risk for acute adrenal insufficiency.  Hospital Physician Journal, 2003;33-44.
  31. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola CM.  Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.  J Clin Endocrinol Metab, 89:142-149, 2004.
  32. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt, BD, Matsumoto AM, Bremner WJ, Tenover JL.  Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.. J Clin Endocrinol Metab, 2004;89:503-510.
  33. Herbst KL, Coviello AD, Page S, Amory JK, Anawalt BD, Bremner WJ.  A single dose of the potent gonadotropin releasing-hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men.  J Clin Endocrinol Metab, 2004;89:5959-5965.
  34. Coviello AD, Bremner WJ, Matsumoto AM, Herbst KL, Amory JK, Anawalt BD, Yan X, Brown TR, Wright WW, Zirkin BR, Jarow JP.  Intratesticular testosterone concentrations comparable to serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.  J Androl, 2004;25:931-938.
  35. Cornia PB and Anawalt BD.  Male hormonal contraception.  Expert Opin Emerg Drugs, 2004;9:335-344.
  36. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ.  Testosterone                                                                               administration Suppresses Adiponectin Levels in Men.  J Androl, 2005;26:85-92.
  37. Page ST, Amory JK, DuBois Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.  Exogenous testosterone alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum testosterone.  J Clin Endocrinol Metab, 2005;90(3):1502-10.
  38. Anawalt BD, Amory JK, Herbst KL, Coviello AD, Page ST, Bremner WJ, Matsumoto AMIntramuscular enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial. J Androl. 2005;26(3):405-13.
  39. Coviello AD, Matsumoto AM, Bremner WJ, Herbst KL, Amory JK, Anawalt BD, Sutton PL, Wright WW, Brown T, Yan X, Zirkin BR, Jarow JP.  Low dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone induced gonadotropin suppression.  J Clin Endocrinol Metab. 2005 ;90(5):2595-602.
  40. Darby E and Anawalt BD.  Male hypogonadism:  an update on diagnosis and treatment.  Treat Endocrinol.  2005;4(5):292-309
  41. Cornia PB and Anawalt BD.  Male hormonal contraceptives:  a potentially patentable and profitable product.  Expert Opinion on Therapeutic Patents.  2005, 15:1727-1737.
  42. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C and the Hormonal Male Contraception Summit Group. The rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.  Lancet.  2006;367:1412-20.
  43. Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ.  Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist, J Clin Endocrinol Metab. 2006;91:4374-80.
  44. Shannon MH and Anawalt BD.  Preparation for colonoscopy in patients with diabetes mellitus.  Diabetes Self-Management, 2006; September, 61.
  45. Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ.  Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.  Contraception, 2007;75:218-23.
  46. Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, Walker SE, Haberer LJ, Clark RV.  The effect of 5α-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.   J Clin Endocrinol Metab, 2007;92:1659-65.

 

  1. Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ.  Elevated end-of-treatment serum INSL-3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception.  J Androl,  2007;28(4):548-54.

 

  1. BD Anawalt.  Update on the development of male hormonal contraceptives.  Curr Op Invest Drugs, 2007;8:318-323.

 

  1. Page ST, Kalhorn TF, Bremner WJ, Anawalt BD, Matsumoto AM, Amory JK.  Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment.  J Androl. 2007;28:734-41.

 

  1. Amory JK, Coviello AD, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ.  Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.
    Fertil Steril. 2008;89:380-6.

 

  1. Amory JK,Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Page ST, Bremner W, Walker SE, Haberer LJ, Clark RV.   The effect of 5-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function. J Urol, 2008;179:2333-8.

 

  1. Liu PY, Swerdloff RS, Anawalt BD, Anderson RA, Bremner WJ, Elliesen J, Gu YQ, Kersemaekers WM, McLachlan RI, Meriggiola MC, Nieschlag E, Sitruk-Ware R, Vogelsong K, Wang XH, Wu FC, Zitzmann M, Wang CDeterminants of the Rate and Extent of Spermatogenic Suppression during Hormonal Male Contraception: An Integrated Analysis.  J Clin Endocrinol Metab. 2008;93;1774-83.

 

  1. Roth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST. Serum LH Correlates Highly with Intratesticular Steroid Levels in Normal Men.

J Androl. 2010;31:138-45.

 

  1. Anawalt BD. Guidelines for testosterone therapy for men:  how to avoid a mad (t)ea party by getting personal.  J Clin Endocrinol Metab, 2010;95:2614-7.

 

 

  1. Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck B, Bremner WJ, Amory JK.  Dose-dependent increase in intratesticular testosterone by very low dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency.  J Clin Endocrinol Metab, 2010;95:3806-13.
  2. Etzel JP, Larson MF, Anawalt BD, Collins J, Dominitz JA.  Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines.  Inflammatory Bowel Diseases, 2011;17:2122-29.
  3. Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck B, Bremner WJ, Amory JK.  The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men.  J Clin Endocrinol Metab, 2011;96:1175-81.
  4. Anawalt BD, Hotaling JM, Walsh TJ, Matsumoto AM. Performance of Total Testosterone Measurements to Predict Free Testosterone in the Biochemical Evaluation of Male Hypogonadism.  J Urol, 2012; 187:1369-73.
  5. Shoeb M, Merel SE, Blackley-Jackson M, Anawalt BD. “Can we just stop and talk?”  Patients value verbal communication about discharge care plans.  J Hosp Med, 2012 July/Aug 23 doi: 10.1002/jhm. [Epub ahead of print].
  6. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM.  Testosterone treatment and mortality in men with low testosterone levels.  J Clin Endocrinol Metab. 2012;97:2050-8.
  7. Roth MY, Nya-Ngatchou JJS, Lin K, Page ST, Anawalt BD, Matsumoto AM, Marck B, Bremner WJ, Amory JK. Androgen synthesis in the gonadotropin suppressed human testes can be markedly suppressed by ketoconazole.  J Clin Endocrinol Metab. 2013;98:1198-20.
  8. Anawalt BD.  The silent spermatozoon: are man-made endocrine disruptors killing male fertility? Asian Journal of Andrology.  2013;15:165-8.
  9. Roth MY, Lin K, Bay K, Amory JK, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Page ST.  Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. Fertil Steril. 2013;99:132-9.
  10. Anawalt BD.  Approach to Male Infertility and Induction of Spermatogenesis.  J Clin Endocrinol Metab.  2013;98:3532-42.
  11. Anawalt BD.  Is Men’s Health Just a Single Letter?  J Clin Endocrinol Metab.  2014;99:70-2.
  12. Anawalt BD.  Clinical Decisions:  Recommend Against Testosterone Replacement Therapy.  N Engl J Med. 2014371;21:2032-4.
  13. Grossmann M, Anawalt BD, Wu FC.  Clinical practice patterns in the assessment and management of low testosterone in men:  an international survey of endocrinologists.  Clin Endocrinol (Oxf).  2015;82:234-241.
  14. Durvasula R, Kayihan A, Del Bene S, Granich M, Parker G, Anawalt BD, Staiger T.  A multidisciplinary care pathway significantly increases the number of early morning discharges in a large academic medical center.  Qual Manag Health Care. 2015;24:45-51.
  15. Cooper LA, Page ST, Amory JK, Anawalt BD, Matsumoto AM.  The Association of Obesity with Sex Hormone Binding Globulin is Stronger than the Association with Aging - Implications for the Interpretation of Total Testosterone Measurements. Clin Endocrinol (Oxf). 2015;83:828-833.
  16. Bevan J, Newell-Price J, Reynolds R, de Herder W, Anawalt B, Ebeling P, Ball S.  Clinical Endocrinology Education Project: a tribute to Professor Steve Judd. Clin Endocrinol (Oxf). 2015;82:623.
  17. Sparks R, Salskov AH, Chang AS, Wentworth KL, Gupta PP, Staiger TO, Anawalt BD.  Pocket Change: A Simple Educational Intervention Increases Hospitalist Documentation of Comorbidities and Improves Hospital Quality Performance Measures.  Qual Manag Health Care. 2015;24:74-7
  18. Anawalt BD, Bremner WJ.  Reproductive endocrinology: Are intramuscular testosterone injections harmful?  Nat Rev Endocrinol. 2015;11(9):510-511.
  19. Lee AP, Roth MY, Nya-Ngatchou JJ, Lin K, Walsh TJ, Page ST, Matsumoto AM, Bremner WJ, Amory JK and Anawalt, BD.  Testicular Fine Needle Aspiration for the Assessment of Intratesticular Hormone Concentrations.  Asian J Androl. 2016;18:21-24.
  20. Reed SD, Newton KM, Larson JC, Booth-LaForce C, Woods NF, Landis CA, Tolentino E, Carpenter JS, Freeman EW, Joffe H, Anawalt BD, Guthrie KA.  Daily salivary cortisol patterns in midlife women with hot flashes.  Clin Endocrinol (Oxf). 2016;84:672-9.
  21. Anawalt, BD.  The Model T.  J Clin Endocrinol Metab. 2016;101:2640-2.
  22. Anawalt BD and Page ST.  Testosterone and the Brain:  The Power of a Negative Study.  Lancet Diabetes Endocrinol. . 2016;4:632-3.

 

Patient education materials

  1.                       BD Anawalt, GR Cunningham, AM Matsumoto.  Erectile Dysfunction.  Patient Information from the Hormone Foundation.  J Clin Endocrinol Metab.  Dec 2005;90.

 

  1.                       BD Anawalt, AM Matsumoto, P Schlegel.  Infertility and Men.  Patient Information from the Hormone Foundation.  J Clin Endocrinol Metab.  Dec 2005;90.

 

  1.                       BD Anawalt, Ronald Morton, Eric Orwoll. Prostate Cancer and Bone Loss.  Patient Information from the Hormone Foundation.  J Clin Endocrinol Metab.  Apr 2006; 91.

 

  1.                       BD Anawalt, GD Braunstein, AM Matsumoto.  Gynecomastia.  Patient Information from the Hormone Foundation.  J Clin Endocrinol Metab, Jan 2011;96.

 

  1.                       BD Anawalt, Matsumoto AM.  Testosterone Tour.  Hormone Health Network., 2013.  http://www.hormone.org/testosteronetour

 

  1.                       BD Anawalt, Kirk S, Latronico AC, Castro L, Farwell A (co-authors and co-editors).  Menopause map.  Hormone Heath Network, 2014.  http://www.menopausemap.org.

 

Book Chapters

  1. Anawalt BD and Bremner WJ.  Diagnosis and treatment of gonadotropin deficiency in males.  The Diagnosis and Treatment of Pituitary Insufficiency, BioScientifica Ltd, Bristol, UK, 1997.
  2. Anawalt BD.  Male infertility.  Outpatient Medicine.  Fihn and Dewitt.  W.B. Saunders, Philadelphia, 1998.
  3. Anawalt BD.  Erectile dysfunction.  Outpatient Medicine.  Fihn and Dewitt.  W.B. Saunders, Philadelphia, 1998.
  4. Anawalt BD and Bremner WJ.  Endocrinology of male sexual function in WJG Hellstrom, ed.,  Handbook of Andrology,  Allen Press, Lawrence, Kansas, 18-26, 1999.
  5. Meriggiola MC, Bebb RA, Anawalt BD, Matsumoto AM, Paulsen CA, Bremner WJ.  Progestagen-testosterone trials for male contraception.  In M. Rajalakshmi, ed., Male Contraception:  Present and Future, pp 219-234, Wiley Eastern, New Delhi, 1999.
  6. Anawalt, BD. Male Hypogonadism.  In D. Pauuw and M. Migeon, ed.,  Internal Medicine Clerkship guide, 2nd edition, Mosby, St Louis, 264-268, 2003.
  7. Anawalt BD.  Androgens in primary care.  In ed.  Carrie Bagatelle and William J Bremner, Androgens and Health, Humana, Totowa, New Jersey, 419-438, 2003.
  8. Anawalt BD.  Male Reproductive Endocrinology.  In Mark Beers, ed.  Merck Manual 18th edition, Merck & Co., West Point, PA, 1943-1950, 2006.
  9. Anawalt, BD. Male Hypogonadism.  In D. Pauuw, L Burkholder and M. Migeon, ed. Internal Medicine Clerkship guide, 3rd edition, Mosby, St Louis, 289-294, 2008.
  10. Anawalt BD.  Erectile Dysfunction.  In R Porter, ed.  Merck Manual of Patient Symptoms.  Merck Research Laboratories, Whitehouse Station, NJ, 191-197, 2008.
  11. Anawalt BD.  Male Reproductive Endocrinology.  In M Beers, ed.  Merck Manual 19th edition, Merck & Co., West Point, PA, 1943-1950, 2012.
  12. Anawalt BD.  Gynecomastia.  In L Jameson, ed.  Jameson/De Groot:  Endocrinology:  Adult and Pediatric 7th edition, Elsevier, Philadelphia, PA, .
  13. Anawalt BD, Braunstein GD.  Testiscular Disorders.  In Schobach D and Gardner D.  Greenspan’s Basic and Clinical Endocrinology. 10th edition, McGraw-Hill Education. New York, NY, in press.

 

Books

  1. Endocrine Essentials.  2nd Edition.  Ed.  BD Anawalt.  Endocrine Society Press, Chevy Chase, MD, 2012.

 

Other publications

  1. Grant NN and Anawalt BD.  Male hormonal contraception:  an update on research progress.  New Ethicals Journal.  May, 2002 :217-227
  2. Anawalt BD and Jarow JD. Two perspectives on the etiology and treatment of erectile dysfunction:  a matter of the heart and brain.  Endocrine News, 2006;31:8-11.
  3. Anawalt, BD.  T in cheek:  Buccal testosterone as a new treatment for androgen deficiency in men.  US Endocrine Disease Touch Briefings, 2006 (www.touchbriefings.com).
  4. Shores MM, Anawalt, BD and Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels.  URO Today, June 2012
  5. Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Practice Improvement Module, 2013.
  6. Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Maintenance of Certification Module, 2013.
  7. Anawalt BD.  Risks associated with testosterone therapy.  Medscape Diabetes & Endocrinology.  www.medscape.com/viewarticle/822621_3

             

Videos, Web Publications, Course Syllabi

  1. Anawalt, BD.  "Birds and the Bees", University of Washington freshman seminar syllabus, 1995.
  2. Anawalt BD.  Male gonadal disorders.  Endocrinology elective for second year medical students, syllabus contribution, 1995, updated annually to present.
  3. Anawalt BD.  New approaches to gonadal steroid replacement.  Current Concepts in Drug Therapy syllabus, University of Washington 10/97.
  4. Anawalt BD.  Dysfunctional Uterine Bleeding.  Idaho Academy of Family Physicians CME syllabus, Jackpot, NV  11/98.
  5. Anawalt BD.  Hormone replacement therapy in the Land of Oz.  Idaho Academy of Family Physicians CME syllabus, Jackpot, NV  11/98.
  6. Anawalt BD, Metabolic bone disease and disorders of calcium homeostasis.  ACP review course syllabus contribution (Seattle), 1998, updated annually to present.
  7. Anawalt BD, Gonadal disorders.  ACP board review course syllabus (Seattle), 1998, updated annually to present.             
  8. Anawalt BD.  Erectile Dysfunction.  Current Concepts in Drug Therapy syllabus, Seattle, WA 11/98.
  9. Anawalt BD.  The Art of Hormone Replacement Therapy.  Pierce County CME syllabus, 3/99.
  10. Anawalt BD.  Sexuality Issues in Older Adults.  Conference on Aging syllabus.  Tacoma, WA  3/99.
  11. Anawalt BD,  Testosterone replacement therapy in elderly men.  "Meet-the-Professor" syllabus, San Diego, Endocrine Society, 6/99.
  12. Anawalt BD, Blood pressure regulation.  Second year medical school endocrine core course syllabus, UW, 1999, updated annually to present.
  13. Anawalt BD.  Female Sexuality.  Reproductive endocrinology course syllabus contribution, second year medical students, University of Washington, 1999-2002.
  14. Anawalt BD.  Lipid disorders.  ACP board review course syllabus (Seattle), 2000, updated annually to present.
  15. Anawalt BD.  Management of the perimenopausal syndrome.  Alaska Nurse Practitioners Conference syllabus, 2000.
  16. Anawalt BD.  Treatment of testosterone deficiency in elderly men.  Wayne State Endocrine course syllabus, 2000.
  17. Anawalt, BD.  The Burden of Sexual Dysfunction.  Diabetes Update II CME syllabus, Indianapolis, IN, 9/01.
  18. Anawalt, BD.  Endocrinology Pearls.  Washington Chapter ACP-ASIM Scientific Meeting CME syllabus, 10/01.
  19. Anawalt, BD.  Erectile Dysfunction.  "Meet-the-Professor" syllabus, San Francisco, Endocrine Society, 134-139, 2002.
  20. Anawalt BD.  The Endocrinologist’s approach to the infertile couple.  Clinical Endocrinology Update, Endocrine Society, 379-388, October 2002.
  21. Anawalt, BD  Male Contraceptives on the Horizon.  25th Annual Conference:  Advanced Practice in Primary and Acute Care syllabus.  Seattle, WA 10/02.
  22. Anawalt BD.  Erectile Dysfunction, Meet the Professor Syllabus, Philadelphia, Endocrine Society, 6/03.
  23. Anawalt, BD.  Primary Care Approach to Infertility.  Endocrinology for Primary Care Conference syllabus, Ashland, Oregon, 8/03.
  24. Anawalt, BD.  Update on Endocrinology, ACP Board Review Course Syllabus, San Diego, CA 10/03.
  25. Anawalt, BD.  Diabetes Workshop, ACP Board Review Course Syllabus, San Diego, CA 10/03.
  26. Anawalt, BD.  “How to have a pumpkin:  infertility and other gonadal disorders,” Blaine, WA 11/03.
  27. Anawalt, BD.  The nuts and bolts of the diagnosis of male hypogonadism.  Endocrine Society CME. Miami, FL  4/04.
  28. Anawalt, BD.  Male Sexual Dysfunction.  Meet the Professor syllabus, Endocrine Society.  New Orleans, LA, 6/04
  29. Anawalt, BD.  Testosterone Therapy:  Expanding Options for the Treatment of Hypogonadism.  Endocrine Society CME syllabus.  New Orleans, LA, 6/04.
  30. Anawalt, BD.  Male Sexual Dysfunction.  Meet the Professor syllabus,  Endocrine Society.  San Diego, CA, 6/05.
  31. Anawalt, BD.  New Treatments and Use of Biochemical Markers, American College of Physicians, Western Chapter meeting, Seattle, 11/06.
  32. Anawalt, BD.  Male Hypogonadism.  Meet the Professor syllabus,  Endocrine Society.  Boston, MA, 6/06.
  33. Anawalt, BD.  Diagnosis of Male Hypogonadism.  Meet the Professor syllabus,  Endocrine Society.  Toronto, Ontario, CA, 7/07.
  34. Anawalt, BD.  Update on Reproductive Endocrinology.  Clinical Endocrinology Update syllabus, Endocrine Society.  San Antonio, TX, 9/07.
  35. Anawalt, BD.  Androgen therapy for women.  Clinical Endocrinology Update syllabus, Endocrine Society.  San Antonio, TX, 9/07.
  36. Anawalt, BD.  Management of male hypogonadism.  Meet the Professor syllabus, American Association of Clinical Endocrinologists, Orlando, FL, 5/08.
  37. Anawalt, BD.  Management of male hypogonadism.  Meet the Professor syllabus, Endocrine Society.  San Francisco, CA, 6/08.
  38. Anawalt, BD.  Review of male and female reproductive endocrinology.  Endocrine Society Board Review.  Boston, MA, 9/08.
  39. Anawalt, BD.  Management of male hypogonadism.   Clinical Endocrinology Update syllabus, Endocrine Society.  Boston, MA, 9/08.
  40. Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus,  Boston, MA 10/08.
  41. Anawalt, BD.  Male Hypogonadism Treatment Update and Controversies, Clinical Endocrinology Update syllabus, Boston, MA 10/08.
  42. Anawalt, BD.  Evaluation and treatment of hypogonadism in the aging male.  Clinical Endocrinology syllabus, Atlanta, GA, 10/09.
  43. Anawalt, BD.  Management of male infertility. Clinical Endocrinology syllabus, Atlanta, GA, 10/09.
  44.                    Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Atlanta, GA, 10/09.
  45.                    Anawalt, BD. Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Los Angeles, CA, 10/10.
  46.                    Anawalt, BD.  Thyroid Disorders.   Seattle ACP Board Review Course, 7/11.
  47. Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Nashville, TN, 9/11.
  48.                    Anawalt, BD. Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Los Angeles, CA, 10/10.
  49.                    Anawalt, BD.  Thyroid Disorders.   Seattle ACP Board Review Course, 7/11.
  50. Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Nashville, TN, 9/11.
  51. Anawalt, BD.  Male Reproductive Disorders. Endocrine Society Annual Board Review syllabus, Miami, Fl, 9/12.
  52. Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Maintenance of Certification Module, San Francisco, CA 6/13.
  53. Anawalt, BD.  Male Infertility.  Endocrine Society Clinical Endocrinology Update, New Orleans, LA, 9/13.
  54. Anawalt, BD.  Erectile Dysfunction; Meet the Professor.  Endocrine Society Clinical Endocrinology Update, New Orleans, LA, 9/13.
  55. Anawalt, BD.  Male Reproductive Disorders. Endocrine Society Annual Board Review syllabus, New Orleans, LA, 9/13.
  56. Anawalt, BD.  Male Reproductive Disorders. Endocrine Society Annual Board Review syllabus, San Francisco, CA, 9/14.
  57. Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Maintenance of Certification Module, San Francisco, CA 9/14.
  58. Anawalt BD.  Male Reproduction, Year in Review.  Endocrine Society Annual Meeting, San Diego, CA, 3/15.
  59. Anawalt BD.  Drug Therapy:  Update in Men’s Health.  Current Concepts in Drug Therapy, University of Washington, Seattle Washington 4/15. 
  60. Anawalt BD.  Male Infertility.  Endocrine Society of Australia Seminar meeting, Melbourne, Australia, 5/15.
  61. Anawalt BD.  T—Is it only for old Republicans?. Endocrine Society of Australia Seminar meeting, Melbourne, Australia, 5/15.
  62. Anawalt BD and JD Zajac.  Men’s Health Master Class.  Endocrine Society of Australia Seminar meeting, Melbourne, Australia, 5/15.
  63. Anawalt BD.  To T or not T?  Grand Rounds, New York University Department of Medicine, New York, New York. 6/15.
  64. Anawalt, BD.  Testosterone Therapy in Men; Meet the Professor.  Endocrine Society Clinical Endocrinology Update, Miami, FL 9/15.
  65. Anawalt, BD.  Male Infertility in the Endocrinology Clinic.  Endocrine Society Clinical Endocrinology Update, Miami, FL 9/15.

 

Abstracts:

 

1.  Walter RM, Uriu-Hare JY, Oster MH, Anawalt BD, Olin KL, Keen CL.  Trace elements status of poorly controlled and retinopathic diabetics.  The Endocrine Society, 1989.

 

2.  Walter RM, Anawalt BD, Grecu EO, Okimura MD.  Thyrotropin releasing hormone may be a nonspecific stimulator of growth hormone in man.  Neuroendocrinology 52: Supplement 1, 1990.

 

3.  Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Keen CL.  Trace element and peroxidative status in complications of diabetes mellitus.  Clinical Research 39:1991.

 

4.  Anawalt BD and Wipf J.   Fresh frozen plasma for perioperative reversal of anticoagulation in a patient with a mechanical prosthetic heart valve.  Washington chapter of ACP meetings, 1992.

 

5.  Anawalt BD, Bebb RA, Christensen RB, Bremner WJ, and Matsumoto AM.  High-dose testosterone treatment in normal men:  Dose-dependent suppression of gonadotropins.  Journal of Investigative Medicine 43:128B, 1995.

 

6.  Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ and Matsumoto AM.  Combination levonorgestrel plus testosterone induces a greater percentage decrease in gonadotropins than testosterone alone.  Journal of Investigative Medicine 43:128B, 1995. 

 

7.  Anawalt BD, Bebb RA, Christensen RB, Bremner WJ, and Matsumoto AM.  High-dose testosterone treatment in normal men:  Dose-dependent suppression of gonadotropins.  Abstract P2-133. The Endocrine Society, Washington, DC, 1995.

 

8.  Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ and Matsumoto AM.  Inadequate gonadotropin suppression:  A reason for lack of contraceptive efficacy in hormonal male contraception.  Abstract P2-134. The Endocrine Society, Washington, DC, 1995.

 

9.  Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, and Bremner WJ.  Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction.  Journal of Investigative Medicine 44:177A,1996.

 

10.  Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, and Bremner WJ.  Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction.  OR58-3. 10th International Congress of Endocrinology, San Francisco, 1996.

 

11.  Matsumoto AM, Anawalt BD, Bebb RA, Paulsen CA, and Bremner WJ.  Low dosage combinations of levonorgestrel (LNG) plus testosterone enanthate (TE) as a potential male contraceptive approach.     P2-599. 10th International Congress of Endocrinology, San Francisco, 1996.

 

12.  Anawalt BD, Bebb RA, Bremner WJ, and Matsumoto AM.  Lower dosage levonorgestrel (LNG) and testosterone enanthate (TE):  Equally effective spermatogenic suppression and fewer metabolic side effects.  Journal of Investigative Medicine, 45:94A, 1997.

 

13.  Meriggiola MC, Costantino A, Anawalt BD, Di Cinteo G, Valdiserri A, Matsumoto AM, Flamigni C, Bremner WJ.  Testosterone enanthate plus cyproterone acetate induces a similar gonadotropin decrease but a more profound spermatogenic suppression compare to levonorgestrel plus testosterone enanthate.  International Andrology Meeting, Salzburg, Austria, 1997.

 

14.  Anawalt BD, Bebb RA, Bagatell CJ, Matsumoto AM, and Bremner WJ.  Combination low-dosage testosterone and desogestrel effectively suppresses spermatogenesis but also causes modest suppression of HDL levels. P1-328. The Endocrine Society, Minneapolis, 1997.

 

15.  Swerdloff RS, Bagatell CJ, Wang C, Davidson T, Steiner B, Anawalt BD, Fidel M, and Bremner WJ.  Maintenance of azoospermia and severe oligospermia (induced by GnRH-A plus testosterone) by testosterone alone.   The Endocrine Society, Minneapolis, 1997.

 

16.  Anawalt BD, Bebb RA, Bremner WJ, and Matsumoto AM.  Lower dosage levonorgestrel (LNG) and testosterone enanthate (TE):  Equally effective spermatogenic suppression and fewer metabolic side effects.  P1-328. The Endocrine Society, Minneapolis, 1997.

 

17.  Smyth CM, Anawalt BD, Matsumoto AM, Bagatell CJ, and Bremner WJ.  Serum osteocalcin levels, a marker of bone formation, rapidly decrease in normal men with experimentally-induced testicular failure.   P3-231. The Endocrine Society, Minneapolis, 1997.

 

18.  Gruenewald DG, Anawalt BD, Gilcriest J, Bremner WJ and Matsumoto AM.  Development of a clinic for the management of benign prostatic hyperplasia in a primary care setting.  American Geriatrics Society Annual Meeting, 1997.

 

19.  Cherrier MM, Craft S, Bremner WJ, Anawalt BD, Gibson L, and Matsumoto AM.  Cognitive effects of exogenous administration in eugonadal and hypogonadal males.  International Neuropsychological Society, Honolulu, 1998.

 

20.  Anawalt BD, Amory JK, Herbst KL, Matsumoto AM, and Bremner WJ.  Testosterone administration to normal men decreases truncal and total body fat.  Journal of Investigative Medicine, 47(2):A22, 1999.

 

21.  Herbst KL, Anawalt BD, Cherrier M, Craft S, Matsumoto AM, and Bremner WJ.  Testosterone administration improves spatial and verbal memory in normal men.  Journal of Investigative Medicine, 47(2):A23, 1999.

 

22.  Amory JK, Chansky HA, Chansky KI, Hoey C, Anawalt BD, Matsumoto AM, and Bremner WJ.  High-dose testosterone enanthate decreases length of hospital stay in elderly men undergoing knee replacement surgery.  OR9-3. Endocrine Society, San Diego, 1999.

 

23.  Anawalt BD, Amory JK, Herbst KL, Matsumoto AM, and Bremner WJ.  Testosterone administration to normal men decreases truncal and total body fat. OR2-4. Endocrine Society, San Diego, 1999.

 

24.  Herbst KL, Anawalt BD, Cherrier M, Craft S, Matsumoto AM, and Bremner WJ.  Testosterone administration improves spatial and verbal memory in normal men.   Endocrine Society, San Diego, 1999.

 

25.  Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, and Bremner WJ.  Testosterone increases lean body mass without increasing body weight.  J Invest Med, 48:69A, 2000.

 

26.  Anawalt BD, Amory JK, Herbst KL, Bremner WJ, and Matsumoto AM.  Lower dosage levonorgestrel plus testosterone effectively suppresses spermatogenesis without causing weight gain.  J Invest Med, 48:12A, 2000.

 

27.  Amory JK, Anawalt BD, Blaskovich PD, Gilchriest J, Nuwayser ES, Matsumoto AM.  Safety and pharmacokinetics of testosterone release from a biodegradable polymer in hypogonadal men. J Androl 21(Suppl):74, 2000.

 

28.  Dick S, Anawalt BD, Amory JK, Herbst KL, Bremner WJ, and Matsumoto AM.  Lower dosage levonorgestrel plus testosterone enanthate effectively suppresses spermatogenesis without causing weight gain.  P-2353. Endocrine Society, Toronto, 2000.

 

  1. Herbst KL, Anawalt BD, Amory JK, Matsumoto AM, and Bremner WJ.  Testosterone increases lean body mass without increasing body weight.  P-2354. Endocrine Society, Toronto, 2000.

 

  1. Amory JK, Bremner WJ, Herbst KL, Matsumoto AM, and Anawalt BD.  Testosterone rapidly increases vertebral bone density in normal young men.  P-2355. Endocrine Society, Toronto, 2000.

 

  1. Herbst KL, Anawalt BD,  Amory JK, Nosbisch C, Bremner WJ.  A potent new gonadotropin releasing hormone (GnRH) antagonist without side effects.  Endocrine Society, Denver, 2001.

 

  1. Bebb RA, Anawalt BD, Wade Frolich J, Basson R, Hoens A, Lavery MJ, Copp DH.  A randomized, double blind, placebo controlled trial of testosterone undecanoate administration in aging hypogonadal men:  effects on bone density and body composition.  Endocrine Society, Denver, 2001.

 

  1. Amory JK, Chansky HC, Anawalt BD, Matsumoto AM, Bremner WJ.  Supraphysiologic androgen administration in elderly men undergoing joint replacement surgery.  J Androl (Suppl) Abstract 5/6-084, VIIth International Congress of Andrology, Montreal, CA, 2001.

 

  1. Anawalt BD, Amory JK, Wang C, Swerdloff RS, Dobs AS, Meikle AW, Elbers J, Houwing NS.  Pharmacokinetics of four dose regimens of Andriol Testocaps in hypogonadal men.  Andrology Society, Seattle, WA, 2002.

 

  1. Herbst KL, Coviello AD, Anawalt BD, Amory JK, Bremner WJ.  Acyline, a new potent, long-acting gonadotropin-releasing hormone antagonist safely and significantly suppresses testosterone for greater than two weeks after a single dose.  P2-674.  Endocrine Society, San Francisco, 2002.

 

  1. Coviello AD, Amory JK, Herbst KL, Anawalt BD, Matsumoto A, Bremner WJ. Gonadotropin levels are higher in men who exhibit persistent spermatogenesis on hormonal contraception regimens.   P2-675. Endocrine Society, San Francisco, 2002.

 

  1. Coviello AD, Herbst KL, Amory JK, Anawalt BD, Yan X, Brown T, Wright B, Bremner WJ, Matsumoto AM, Jarow JP. Exogenous testosterone plus levonorgestrel profoundly suppresses intratesticular testosterone and androgenic bioactivity. J Invest Med. 51(Suppl). S155, 2003.

 

  1. Amory JK, NB Watts, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.  Testosterone plus Finasteride increases bone mineral density without increasing prostate volume in older men with low serum testosterone.  J Androl (Suppl). 24:38, 2003.

 

  1. Coviello AD, Herbst KL, Amory JK, Anawalt BD, Yan X, Brown T, Wright B, Bremner WJ, Matsumoto AM, Jarow JP. Exogenous testosterone plus levonorgestrel profoundly suppresses intratesticular testosterone and androgenic bioactivity. J Androl (Suppl) 24:66,2003.

 

  1. Coviello AD, Gilchriest JK, Anawalt BD, Matsumoto AM.  Sustained gonadotropin suppression with subcutaneous testosterone microcapsule injections in normal men:  a potential agent for male hormonal contraception.  Endocrine Society, Philadelphia, 2003.

 

  1. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ.  Short-term effects of androgen manipulation on adiponectin in normal men.  J Invest Med 2004;52:S97.

 

  1. Coviello AD, Herbst KL, Amory JK, Anawalt BD, Sutton PL, Wright WW, Brown T, Yan X, Bremner AM, Zirkin BR, Jarow JP.  Low dose human chorionic gonadotropin maintains intratesticular testosterone in normal men following gonadotropin suppression.  J Invest Med 2004;52:S99.

 

  1. Coviello AD, Herbst KL, Amory JK, Anawalt BD, Sutton PL, Wright WW, Brown T, Yan X, Bremner AM, Zirkin BR, Jarow JP.  Low dose human chorionic gonadotropin maintains intratesticular testosterone in normal men following gonadotropin suppression.  Endocrine Society 86th Annual Meeting, New Orleans, LA, June 2004.10. 

 

  1. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ. Testosterone suppresses adiponectin in normal me. Poster, Annual Meeting of the Endocrine Society, New Orleans, 2004.

 

  1. Page ST, Amory JK, Bowman ED, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.  Exogenous testosterone alone or with finasteride improves physical performance and increases lean body mass in older men with low serum testosterone.  12th International Congress of Endocrinology, Lisbon, Portugal, August, 2004.

 

  1. Page ST, Amory JK, Bowman ED, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL.  Exogenous testosterone alone or with finasteride improves physical performance and increases lean body mass in older men with low serum testosterone.  J Invest Med 2005;54(1):S97.

 

  1. Coviello AD, Herbst KL, McGuinness DM, Anawalt BD, Matsumoto AM, Bremner WJ.  The circulating testicular peptide hormone INSL-3 decreases in men in repsonse to treatment with a hormonal contraceptive regimen but does not account for failure to achieve azoospermia.  Endocrine Society 87th Annual Meeting, San Diego, CA, 2005.

 

  1. Page ST, Amory JK, Anawalt BD, Matsumoto AM, Brockenbrough AT, Irwig MS, Bremner WJ.  Is there a role for gonadotropins-releasing hormone antagonists in male hormonal contraception?  J  Invest Med 2006, 55.

 

  1. Page ST, Amory JK, Anawalt BD, Matsumoto AM, Brockenbrough AT, Irwig MS, Bremner WJ.  Is there a role for gonadotropins-releasing hormone antagonists in male hormonal contraception?  Endocrine Society 88th Annual Meeting, Boston, MA.

 

  1. Page ST, Amory, JK, Anawalt BD, Matsumoto AM, Brockenbrough, AT, Irwig, MS, Bremner WJ.  [OR22-5] Testosterone Gel Combined with Depomedroxyprogesterone (DMPA) Effectively Suppresses Spermatogenesis in Normal Men: A Potential Male Hormonal Contraceptive Regimen. Endocrine Society 88th Annual Meeting, Boston, MA 2006.

 

  1. Page ST, Amory JK, Anawalt BD, Matsumoto AM, Bremner WJ.  Acceptability of testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.  J Invest Med 2007;S138: 381.

 

  1. Clark RV, Amory JK, Wang C, Swerdloff RS, Matsumoto AM, Anawalt BD, Walker SE, Haberer LJ, Bremner WJ. The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men.  Endocrine Society 89th Annual Meeting, Toronto, CA 2007.

 

  1. Amory JK, Coviello AD, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ. Serum 17-Hydroxyprogesterone Strongly Correlates with Intratesticular Testosterone in Gonadotropin-Suppressed Normal Men Receiving Various Doses of Human Chorionic Gonadotropin.  Endocrine Society 89th Annual Meeting, Toronto, CA 2007.

 

  1. Page ST, Kalhorn TF, Bremner WJ, Anawalt BD, Matsumoto AM, sAmory JK.  Serum INSL3, a Leydig Cell Product, Does Not Correlate with Residual Intratesticular Androgens in Men with Suppressed Gonadotropins during Hormonal Contraceptive Treatment.  Endocrine Society 89th Annual Meeting, Toronto, CA 2007.

 

  1. Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Snyder CN, Marck B, Bremner WJ, Amory JK.  The dose response relationship between human chorionic gonadotropin (hCG) and intratesticular testosterone in normal men with experimentally-induced hypogonadism.  Abstract No. P1-387. The Endocrine Society 92th Annual Meeting, San Diego, CA, 2010.

 

  1. Anawalt BD, Hirano L, Hotaling JM, Walsh TJ, Shields A, Matsumoto AM. Total testosterone (T) is a good screening test for male hypogonadism, but should not be used to make a definitive biochemical diagnosis.  Abstract No. P2-458. The Endocrine Society 92th Annual Meeting, San Diego, CA, 2010.

 

  1. Roth MY, Page ST, Lin K, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Amory JK. The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men. Endocr Rev. 2011;32:P1-328. The Endocrine Society 93th Annual Meeting, Boston, MA, June 2011. 

 

  1. Roth MY, Lin K, Bay K, Amory JK Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Page ST. Serum INSL3 concentration is highly correlated with intratesticular testosterone concentration in normal men stimulated by very low dose human chorionic gonadotropin during experimental gonadotropin deficiency.  Andrology Society Annual Meeting, Phoenix, AZ, April 2012.

 

  1. Roth MY, Lin K, Page ST, Nya-Ngatchou JJS, Anawalt BD, Matsumoto AM, Marck BT, Bremner WJ, Amory JK.  Inhibition of Steroidogenesis in Normal Men with Experimentally Induced Hypogonadotropic Hypogonadism Maximally Decreases Intratesticular Testosterone.  Endocr Rev. 2012;33:Sun 63.  The Endocrine Society 93th Annual Meeting, Houston, TX, June 2012. 


 

Selected presentations

 

Anawalt, BD.  Fresh frozen plasma for perioperative reversal of anticoagulation in a patient with a mechanical prosthetic heart valve.  Washington chapter of ACP meetings, 12/92.

 

Anawalt, BD.  Multiple Endocrine Neoplasias.  Boise VA Department of Medicine Grand Rounds, Boise, ID 3/94.

 

Anawalt, BD.  High-dose testosterone treatment in normal men:  Dose-dependent suppression of gonadotropins.  Western meeting of the American Federation for Clinical Research, Carmel, CA, 2/95.

 

Anawalt, BD.  Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction.  Western meeting of the American Federation for Clinical Research, Carmel, CA, 2/96.

 

Anawalt, BD.  Internists' approach to benign prostatic hypertrophy.  St. Patrick Hospital Medicine Rounds, Missoula, MT, 5/96.

 

Anawalt, BD.  Serum inhibin B levels reflect Sertoli cell function in normal men and in men with testicular dysfunction. 10th International Congress of Endocrinology, San Francisco, CA 6/96.

 

Anawalt, BD.  Update on hypothyroidism and hyperthyroidism.  Northwest Primary Care Practioners' Conference, Seattle, WA 10/96.

 

Anawalt BD.  Lower dosage levonorgestrel and testosterone enanthate:  Equally effective spermatogenic suppression and fewer metabolic side effects.   Western meeting of the American Federation for Clinical Research, Carmel, CA 2/97.

 

Anawalt BD.  Lower dosage levonorgestrel (LNG) and testosterone enanthate (TE):  Equally effective spermatogenic suppression and fewer metabolic side effects.   The Endocrine Society, Minneapolis, MN 6/97.

 

Anawalt BD.  Testosterone and men's health.  "Northwest Afternoon" Channel 13 Seattle, WA 7/97.

 

Anawalt BD and Cummings D.  New approaches to gonadal steroid replacements.  Current Concepts in Drug Therapy, University of Washington 10/97.

 

Anawalt BD.  "Sex, lies and videotape:  new uses for androgens".  University of Washington Grand Rounds 1/98.

 

Anawalt BD.  Hormone replacement therapy in the postmenopausal woman.  Geriatric Nurse Practitioners of Puget Sound Conference, Seattle, WA 3/98.

 

Anawalt BD.  Hormone replacement therapy.  Endocrine Days, Seattle, WA  4/98.

 

Anawalt BD.  Calcium and bone disorders.  ACP Board Review Course Seattle, WA 7/98.

 

Anawalt BD.  Gonadal disorders.  ACP Board Review Course Seattle, WA 7/98.

 

Anawalt BD.  Erectile dysfunction.  Northwest Pharmacists' Association, Seattle, WA 10/98.

 

Anawalt BD.  Erectile Dysfunction.  Current Concepts in Drug Therapy, Seattle, WA 11/98.

 

Anawalt BD.  Dysfunctional Uterine Bleeding.  Idaho Academy of Family Physicians Conference, Jackpot, NV  11/98.

 

Anawalt BD.  Hormone replacement therapy in the Land of Oz.  Idaho Academy of Family Physicians Conference, Jackpot, NV 11/98.

 

Anawalt BD.  Dysfunctional uterine bleeding.  Spokane Nurse Practitioner's Association, Spokane, WA  1/99.

 

Anawalt, BD.  Testosterone administration to normal men decreases truncal and total body fat.  Western meeting of the American Federation for Clinical Research, Carmel, CA 2/99.

 

Anawalt BD.  Phytoestrogens, androgen replacement therapy and other novelties in the treatment of perimenopausal women.  Seattle Gynecology Association, Seattle, WA. 3/99.

 

Anawalt BD.  Sexuality Issues in Older Adults.  Conference on Aging.  Tacoma, WA 3/99.

 

Anawalt BD.  Effects of testosterone on body composition and composition in young men.  Northwest Reproductive Sciences Symposium.  Portland, OR 5/99.

 

Anawalt BD.  Erectile Dysfunction.  Medicine Man Talk Show (KOMO radio show) Seattle, WA 5/99.

 

Anawalt, BD.  Testosterone replacement therapy in elderly men.  The Endocrine Society, San Diego, CA 6/99.

 

Anawalt BD.  Testosterone administration to normal men decreases truncal and total body fat. The Endocrine Society, San Diego, CA 6/99.

 

Anawalt, BD.  Gonadal Disorders.  ACP Review course, Seattle, WA 7/99.

 

Anawalt, BD.  New uses for androgens.  Seattle Dermatology Society, Seattle, WA 11/99.

 

Anawalt, BD.  Lower dosage levonorgestrel plus testosterone effectively suppresses spermatogenesis without causing weight gain.  Western AFMR meeting, Carmel, CA 2/00.

 

Anawalt, BD.  "Update on Osteoporosis",  Seattle Area Society of Health System Pharmacists.  SeaTac, WA 3/00.

 

Anawalt, BD.  "Mind-altering drugs and sex", Endocrine Days. Seattle, WA 3/00.

 

Anawalt, BD.  Update on dyslipidemias, Medical Grand Rounds, St Mary’s Hospital, Walla Walla, WA, 5/00.

 

Anawalt, BD.  New potential uses of androgen therapy, International Endocrine Society Meeting, Toronto, Canada 6/00.

 

Anawalt, BD.  Gonadal Disorders.  ACP Review course, Seattle, WA 7/00.

 

Anawalt, BD.  Lipid disorders.  ACP Review course, Seattle, WA 7/00.

 

Anawalt, BD.  Calcium and bone disorders.  ACP Review course, Seattle, WA 7/00.

 

Anawalt, BD.  Management of perimenopausal symptoms.  Alaska Nurse Practitioners Conference, Anchorage, AK 10/00.

 

Anawalt, BD.  Treatment of testosterone deficiency in the elderly male.  Wayne State Endocrine Review Course, Detroit, MI 11/00.

 

Anawalt, BD.  Treatment of hypertension in diabetes mellitus.  University of Washington Diabetes Update 2000, Seattle, WA 11/00.

 

Anawalt, BD.  Evaluation of edema.  Danang Medical Center, Danang, Vietnam 5/01.

 

Anawalt, BD.  Thyroid disorders.  Danang Medical Center, Danang, Vietnam 5/01.

 

Anawalt, BD.  Gonadal disorders.  Danang Medical Center, Danang, Vietnam 5/01.

 

Anawalt, BD.  Meet the Professor clinical case discussion.  Endocrine Society, Denver, CO 6/01.

 

Anawalt , BD.  Endocrine Society Oral Session Moderator, Denver, CO 6/01.

 

Anawalt, BD.  Gonadal Disorders.  ACP Review course, Seattle, WA 7/01.

 

Anawalt, BD.  Lipid disorders.  ACP Review course, Seattle, WA 7/01.

 

Anawalt, BD.  Calcium and bone disorders.  ACP Review course, Seattle, WA 7/01.

 

Anawalt, BD.  Management of sexual dysfunction in diabetic patients.  University of Indiana, Indianapolis, IN 9/01.

 

Anawalt, BD.  Endocrinology Clinical Pearls.  Washington Chapter ACP-ASIM Scientific Meeting Seattle, WA 10/01.

 

Anawalt, BD.  Male hormonal contraception.  31st Annual Reproductive Health Conference, Seattle, WA 3/02.

 

Anawalt, BD.  Update on management of dyslipidemias.  Cardiovascular Health:  Effective Strategies, Tacoma, WA 5/02.

 

Anawalt, BD.  Update in Andrology.  Meeting the Professor at the national ACP Meeting, Philadelphia, PA, 4/02.

 

Anawalt, BD.  Erectile Dysfunction.  Meet the Professor at the Endocrine Society, San Francisco, CA, 6/02.

 

Anawalt, BD.  The endocrinologist’s approach to the infertile couple.  Endocrine Society’s Clinical Endocrinology Update, Portland, OR, 10/02.

 

Anawalt, BD  Male Contraceptives on the Horizon.  25th Annual Conference:  Advanced Practice in Primary and Acute Care.  Seattle, WA 10/02.

 

Anawalt, BD.  Thyroid Workshop.  National ACP Board Review Re-certification Course, San Diego, CA 10/02.

 

Anawalt, BD.  Diabetes Workshop.  National ACP Board Review Re-certification Course, San Diego, CA 10/02.

 

Anawalt, BD.  Update in Endocrinology. National ACP Board Re-certification Review Course, San Diego, CA 10/02.

 

Anawalt, BD.  Male Contraception.  25th Annual Conference:  Advanced Practice in Primary and Acute Care, Seattle WA 11/02.

 

Anawalt, BD.  “Walking on Sunshine:  Vitamin D in Primary Care”.  Washington State Academy of Physician Assistants State Conference, Seattle, WA 5/03.

 

Anawalt, BD.  Osteoporosis:  Diagnosis and Management.  Washington State Academy of Physician Assistants State Conference, Seattle, WA 5/03.

 

Anawalt, BD.   Vitamin D in Endocrinology.  Endocrine Days, Seattle WA 5/03.

 

Anawalt, BD.  Erectile Dysfunction, Meet the Professor at the Endocrine Society, Denver CO, 6/03.

 

Anawalt, BD.  Primary Care Approach to Infertility.  Endocrinology for Primary Care Conference, Ashland, Oregon, 8/03.

 

Anawalt, BD.  “How to have a pumpkin:  infertility and other gonadal disorders”.  Endocrine Days,  Blaine, WA 11/03.

 

Anawalt, BD.  The nuts and bolts of the diagnosis of male hypogonadism.  Endocrine Society CME. Miami, FL  4/04.

 

Anawalt, BD.  Male Sexual Dysfunction.  Meet the Professor at the Endocrine Society.  New Orleans, LA, 6/04.

 

Anawalt, BD.  Brown-Sequard Bingo.  Endocrine Days, Seattle, WA, 10/04.

 

Anawalt BD.  “Under the Quilt:  The Endocrinology of Sleep”.  University of Washington Grand Rounds, Seattle, WA, 10/04.

 

Anawalt BD.  “Under the Quilt:  The Endocrinology of Sleep”.  Boise VA Grand Rounds, Boise, ID, 12/04.

 

Anawalt BD.  “Under the Quilt:  The Endocrinology of Sleep”.  Seattle Sleep Conference, Seattle, WA, 12/04

 

Anawalt BD.  “Under the Quilt:  The Endocrinology of Sleep”.  University of Cincinatti, Cincinatti, OH 4/05.

 

Anawalt BD.   “Nuts and Bolts of Hypogonadism.”  University of Cincinatti, Cincinatti, OH 4/05.

 

Anawalt, BD.  Male Sexual Dysfunction.  Meet the Professor at the Endocrine Society.  San Diego, CA, 6/05.

 

Anawalt, BD.  Endocrinology of Sex, Endocrine Days, Semiahmoo, WA 10/05.

 

Anawalt, BD.  “From Sunshine to Soap Suds:  What’s Good and Bad for Bones?” Washington State ACP meeting, Seattle, WA 11/05.

 

Anawalt, BD.  “How the Bantam lost his hennies”, Endocrine Days, Seattle, WA 1/06.

 

Anawalt, BD.  “Nuts and Bolts of Hypogonadism, Grand Rounds, Providence Hospital, Portland, OR, 3/06.

 

Anawalt, BD.  “Nuts and Bolts of Hypogonadism, Grand Rounds, St Vincent’s Hospital, Portland, OR, 3/06.

 

Anawalt, BD.  Diagnosis of Male Hypogonadism.  .Meet the Professor at the Endocrine Society.  Boston, MA, 6/06.

 

Anawalt BD.  “Vitamin D:  Walking on sunshine or a trip to the dark side?” Seattle Dermatologic Society.  Seattle, WA, 10/06.

 

Anawalt, BD.  New Treatments of Osteoporosis and Use of Biochemical Markers, American College of Physicians, Western Chapter, Seattle, 11/06.

 

Anawalt, BD. Male hypogonadism.  Boise VA Grand Rounds, Boise, ID, 1/07.

 

Anawalt, BD. Diagnosis of Male Hypogonadism.  Meet the Professor at the Endocrine Society.  Toronto, Canada,  6/07.

Anawalt, BD.  Male Reproduction Update.  Fellow’s Day, Endocrine Society, Toronto, Canada, 6/07.

 

Anawalt, BD.  Update on Reproductive Endocrinology.  Clinical Endocrinology Update syllabus, Endocrine Society.  San Antonio, TX, 9/07.

 

Anawalt, BD.  Androgen therapy for women.  Meet-The-Professor, Endocrine Society.  San Antonio, TX, 9/07.

 

Anawalt, BD.  Teens and twenties:  time of hormones popping and popping hormones.  Grand Rounds, University of Washington, Seattle, WA, 1/08.

 

Anawalt, BD.  Wrinkles in T:  abnormal gonadal function tests.  Endocrine Days, Vancouver, British Columbia, 1/08.

 

Anawalt, BD.  How to write a manuscript.  Western Society of American Federation Medical Research annual meeting.  Carmel, CA 1/08.

 

Anawalt, BD.  Meet-the-Professor:  Management and Diagnosis of Male Hypogonadism.  American Association of Clinical Endocrinologists Annual Meeting.  Orlando, FL 5/08

 

Anawalt, BD.  Meet-the-Professor:  Management and Diagnosis of Male Hypogonadism.  Endocrine Society Annual Meeting.   San Francisco, CA 6/08.

 

Anawalt, BD.  Update in Endocrinology (ABIM module).  Endocrine Society Annual Meeting.   San Francisco, CA 6/08.

 

Anawalt, BD.   Male hypogonadism,  Fellow’s Day, Endocrine Society.  San Francisco, CA 6/08.

 

Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review, Boston, MA 10/08.

 

Anawalt, BD.  Male Hypogonadism Treatment Update and Controversies, Clinical Endocrinology Update, Boston, MA 10/08.

 

Anawalt, BD.  Male  Hypogonadism Treatment Update.  University of Utah Endocrinology Grand Rounds, Salt Lake City, UT, 1/09.

 

Anawalt, BD.  How to write a manuscript.  Western Society of American Federation Medical Research annual meeting.  Carmel, CA 1/09.

 

Anawalt, BD.  Meet-The-Professor:  Induction of spermatogenesis and male fertility. Endocrine Society Annual Meeting.   Washington, D.C. 6/09.

 

Anawalt, BD.   Male hypogonadism,  Fellow’s Day, Endocrine Society. Washington, D.C. 6/09.

 

Anawalt, BD.  Topics in Male Hypogonadism.  Speaker and Program Director of CME symposium, Endocrine Society.  Washington, D.C. 6/09.

 

Anawalt, BD.  36th Annual Advances in Family Practice and Primary Care.  University of Washington, Seattle, Washington, 9/09.

 

Anawalt, BD.  Evaluation and treatment of hypogonadism in the aging male.  Clinical Endocrinology Update, Atlanta, GA 10/09.

 

Anawalt, BD.  Management of male infertility. Clinical Endocrinology Update, Atlanta, GA 10/09.

 

Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review syllabus, Atlanta, GA 10/09.

 

Anawalt, BD.   Male hypogonadism, Medical Grand Rounds, University of Nebraska, Omaha, NE 3/10.

 

Anawalt, BD.  Male hormonal contraception, Research Rounds, University of Nebraska, Omaha, NE 3/10.

 

Anawalt, BD.  Meet-The-Professor:  Induction of spermatogenesis and male fertility. Endocrine Society Annual Meeting, San Diego, CA 6/10.

 

Anawalt, BD, John Levine.  Trivia Cup, Endocrine Society, San Diego CA 6/10.

 

Anawalt, BD.   Male hypogonadism, Fellow’s Day, Endocrine Society. San Diego, CA 6/10.

 

Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review, Los Angeles, 10/10.

 

Tuttle M, Haugen B, Anawalt BD.  Difficult Thyroid Cancer Cases, Master Clinician Series, Endocrine Society Annual Meeting, Boston, MA, 6/11

 

Anawalt, BD, John Levine.  Trivia Cup, Endocrine Society, Boston, MA, 6/11. 

 

Anawalt, BD.  Male and Female Reproductive Disorders.  Endocrine Society Annual Board Review, Nashville, TN, 9/11.

 

Anawalt, BD.  How to prepare for medical school. University of Santa Clara AMSA Dean’s Series. , Santa Clara, CA, 1/12

Anawalt, BD.  Life in Medicine.  University of Santa Clara AMSA Dean’s Series. Santa Clara, CA, 1/12

 

Anawalt, BD.  Diagnosis of Male Hypogonadism.  Endocrine Days, Seattle, WA, 2/12.

 

Anawalt, BD.  Diagnosis of Male Hypogonadism:  How to Crack the Nut”.  Boise VA Grand Rounds, Boise, ID,  2/12.

 

Anawalt, BD.  Diagnosis of Male H              ypogonadism.  University of Cincinnati Grand Rounds, Cincinnati, OH, 4/12.

 

Anawalt, BD.  Management of Male Infertility.  Endocrine Rounds, Cincinnati, OH, 4/12.

 

Anawalt, BD.  Transitions in T:  Pubertal disorders of the male gonadal axis.  Children’s Hospital, Seattle, WA 5/12.

 

Anawalt BD and Bebb RA.  Secondary hypogonadism due to opiates, corticosteroids and androgenic anabolic steroids.  Clinical Management Forum.  Houston, TX, 6/12.

 

Anawalt, BD and Levine, J.  Trivia Cup, Endocrine Society, Houston, TX, 6/12.

 

Anawalt, BD.  Male Reproductive Disorders.  Endocrine Society Annual Board Review Miami, FL, 9/12.

 

Anawalt, BD.  Male Hypogonadism.  Primary Care Rounds, Roosevelt Clinic, Seattle, WA 11/12.

 

Anawalt, BD and Levine, J.  Trivia Cup, Endocrine Society, San Francisco, CA 6/13.

 

Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Maintenance of Certification Module, San Francisco, CA 6/13.

 

Anawalt, BD.   Male Reproductive Disorders.  Endocrine Society Annual Board Review, New Orleans, LA, 9/13.

 

Anawalt, BD.  Male Infertility.  Endocrine Society Clinical Endocrinology Update, New Orleans, LA, 9/13.

 

Anawalt, BD.  Erectile Dysfunction. Meet the Professor.  Endocrine Society Clinical Endocrinology Update, New Orleans, LA, 9/13.

 

Anawalt, BD. Male Hypogonadism.  EndoBridge, Antalya, Turkey, 10/13.

 

Anawalt, BD. Male Reproductive Disorders.  EndoBridge, Antalya, Turkey, 10/13.

 

Anawalt, BD.  Management of Idiopathic Hypogonadotropic Hypogonadism, Mumbai, India, 11/13.

 

Anawalt, BD.  Erectile Dysfunction.  Mumbai, India, 11/13.

 

Anawalt, BD.  PEDometry:  use and abuse of performance-enhancing drugs by athletes.  Grand Rounds, University of Washington, 2/14.

 

Anawalt, BD and Levine, J.  Trivia Cup, Endocrine Society, Chicago, IL, 6/14.

 

Anawalt, BD.  Male Reproductive Disorders. Endocrine Society Annual Board Review Course, San Francisco, CA, 9/14.

 

Anawalt BD, Matsumoto AM, Basaria, S.  Endocrine Society Male Hypogonadism Maintenance of Certification Module, San Francisco, CA 9/14.

Anawalt BD.  Male Infertility.  Snowmass Clinical Diabetes and Endocrinology 2015.  Snowmass, CO, 1/15

 

Anawalt BD.  Erectile Dysfunction.  Snowmass Clinical Diabetes and Endocrinology 2015.  Snowmass, CO 1/15.

 

Anawalt BD.  Male Reproduction, Year in Review.  Endocrine Society, San Diego, CA 3/15.

 

Anawalt BD.  Male Infertility in the Endocrinology Clinic.  Plenary session, Endocrine Society of Australia, Sidney, Australia 5/15.

 

Anawalt BD.  Male hypogonadism.  Endocrine Society of Australia, Sidney, Australia 5/15.

 

Anawalt BD.  Male Hypogonadism:  To T or not to T.  New York University Grand Rounds, New York City, NY 5/15.

 

Anawalt BD.  Male Infertility in the Endocrinology Clinic.  Endocrine Society Clinical Endocrinology Update.  Miami, FL, 9/15.

 

Anawalt BD.  Meet the Professor:  Testosterone therapy in Men.  Endocrine Society Clinical Endocrinology Update.  Miami, FL, 9/15.

 

Anawalt BD.  Male Hypogonadism.  Alaska Native Medical Center Rounds.  Anchorage, Alaska.  11/15

 

Anawalt BD.  Male Hypogonadism.  Alaska Providence Hospital Ground Rounds.  Anchorage, Alaska.  11/15

 

Anawalt BD. Year in Review:  Male Reproduction.  Endo Days, Seattle, WA.  4/16

 

Anawalt BD.  Testosterone:  when will the bubble burst?  International Congress of Endocrinology, Beijing China.  8/16

 

Anawalt BD.  Testosterone Replacement Therapy Cases.  Meet the Professor, International Congress of Endocrinology, Beijing China.  8/16

 

Anawalt BD.  Testosterone use and abuse.  Endocrine Society Clinical Endocrinology Update, Seattle, WA.  9/16

 

Matsumoto AM, Auchus RA, Anawalt BD. Implications of Testosterone Use in Anti-Doping, 15th Annual United States Anti-Doping Association Symposium on Anti-Doping Science.  Bellevue, WA, 10/16

 

Anawalt BD.  Male Hypogonadism and Testosterone Replacement Therapy.  Washington Association of Physician of Physicians of Indian Origin Annual Interdisciplinary Conference. Bellevue, WA, 1016.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bradley Anawalt                                                                   Curriculum Vitae                                                                      1